Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Murea

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Stem Cells (Dayton, Ohio)|December 1, 1995
High-dose therapy with peripheral blood progenitor cell support in patients with non-Hodgkin's lymphomaR Haas, S Murea, H Goldschmidt, et al.
Bone Marrow Transplantation|February 1, 1996
High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphomaR Haas, M Moos, R Möhle, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancerR Haas, H Schmid, U Hahn, et al.
British Journal of Haematology|June 1, 1997
Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancerS Hohaus, M Pförsich, S Murea, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Stem Cells (Dayton, Ohio)|December 1, 1995
High-dose therapy with peripheral blood progenitor cell support in patients with non-Hodgkin's lymphomaR Haas, S Murea, H Goldschmidt, et al.
Bone Marrow Transplantation|February 1, 1996
High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphomaR Haas, M Moos, R Möhle, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
Tandem high-dose therapy with ifosfamide, epirubicin, carboplatin and peripheral blood stem cell support is an effective adjuvant treatment for high-risk primary breast cancerR Haas, H Schmid, U Hahn, et al.
British Journal of Haematology|June 1, 1997
Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancerS Hohaus, M Pförsich, S Murea, et al.
Pageof 2